Skip to main content
. 2013 Mar;29(2):249–257. doi: 10.1089/jop.2012.0152

Table 3.

Safety Studies: Ocular Inflammation

 
 
Conjunctival injection
A/C Cell/Fibrin
 
 
  Insertion site Any event Grade >2, >1 weeka Any event Grade >2, >1 weeka Vitreous cell/fibrin Endophthalmitis
# of eyes (%) A/C devices (3 eyes) 3 (100%) 0 2 (67%) 0 0 0
  Vitreous devices (15 eyes) 9 (60%) 0 0 0 0 0
a

Graded 0 to 4 in severity, with finding persisting more than 1 week after the insertion procedure.